Journal of The Korean Glaucoma Society
JOURNAL OF THE KOREAN GLAUCOMA SOCIETY 10
1. 서론
घৈפֳણ൝ઘઅௗݑؘടӋפֳણઅഥ
࠾மघ൛ത੶ܾঅ१ܲӘ१ৡݴࡂടӋીࣛહઌ१ Ҁӆઅࠋش٩ടؘҫઊد)LJ1ऀઌӘشݼ१Ҁӆ ݴࠋش१ఇࣳࣥઅ१ܲࡂടܱԞਁࢉݼ
ടਉӴહઌछࣛமघ൛ടӋઊټ൲ਁ
٩ӸઊࣛӯીടࣳહԔહઌৢ१ௗݑݴടؘҫઊച
ടدനࣳSULPDU\FRQJHQLWDOJODXFRPDਁࣳ
ؘઍୱહ੶़ܾीઊചടӋৢߜࡂહ़زઊކ
VHFRQGDU\JODXFRPDਁؘࣳৢߜઊௗݑࠩઊټد
ऀઌਁࣳઊؘפֳણௗݑৢڝઊघৈפֳણਁࣳ٩އ ઊઊӋઔކ൭ӘਭऀڢਁࣳऀઌӘؘدݳઽڝ ઊઔدפֳણ൝ৈਁࣳއઊઊؘৢڝӘࡘઙੋۙघ
ৈפֳણઅ१ܲਙ൲ਁفനҁزඥࣔೞࡂӋઘഡد
2. 소아녹내장의 약물치료
घৈਁؘࣳEORFNHU WLPRORO EHWD[RORO FDUERQLF
DQK\GUDVHLQKLELWRUGRU]RODPLGH2DJRQLVWEULPRQLGLQHਭ
SURVWDJODQGLQDQDORJODWDQRSURVW4ӶઅৢઊઊӋઔدघ
ৈפֳણઅமੌࣷࣷৢߜWLPROROܾPRQRWKHUDS\ܾࡘ
ഢӄੌਁؘ‘WLPROROടݗഡࠤGRU]RODPLGHടݗڂࠤ’
અഥઊ൭Әѿઔد%ULPRQLGLQHघৈਁࣳ७Ҁഡഥ
࠾અѿ؟ऀઊઔৰࣳ2ंઊടਁؘࣳԙԞઊدघৈਁࣳ
ODWRQRSURVWؘऀઌࡂدടҋઅ൭ӘѿৢടدӋ্ܱ੶
֢MXYHQLOHRSHQDQJOHJODXFRPD6WXUJH:HEHUV\QGURPHӘ
Ӛټפֳણಡඥ֢ઊѿއӄੌDSKDNLFJODXFRPDਁࣳ
੭અഡടҋ൭ӘѿઔدӋࡂӋٻৼد1
ӵघહ੶ܾ࣏ੋടؘৢ٩३ਁඛ़ٻৰ३હઌࡘ ઙੋઍ੶ే़ઔدৢઅੋܞघৈਁސஷৰઔ
ৌৈࣳघৈؘ३હઌࡘઙੋઅസऀઊًٙ३
ࣥৈਭਕৈઅӄੌؘಡඥEORRGEUDLQEDUULHUѿ߸ऀऽടӋ
ৢف࣏ടؘ؟ܲઊۅৰ੍ًࣳ३હઌࡘઙੋਁৢ
ടد2३ࣥৈઅӴੋહऀઌઅࠉી٩ܾކ2ंી٩
ৰݳӘࡻ॥നؘٙࡻന३ࣥৈઅേܞৰݳਁࡻനޓ
ੌહدӴੋહઊࣛفહ੶ܾ௵ࣳORFDOWKHUDSHXWLFOHYHO
ਁઊݱԞനؘࣳৰݳੋܞӘࡻ॥ഡ৩અઽ࣏ੋ
നৡഢ़ઔؘٙઊৢߜઊ३હ੶ܾඛ़ٻޓੌહ
৩અേਁඟࣴٻܾ߳३હઌৢߜઅ٩ؘޓੌ
ৈଔد1گ܅ࣳৢ࣏ੋഢڹ٩ৰݼӋஔૻઊѿ࠷
ৈઊઍ़ܿѿ؟ഡഡ൭Әѿઔؘமघ٩અҫӋઽ
൲ઽܟӋ҆Ҳടң֢৵Ӹਁߛਉ࡚અ
ৢرৈֳؘڢ३હઌඛ़ݴ҆घ१ౄԞഡףܲઊ
Fig. 1.(QODUJHGFRUQHDGXHWRFRQJHQLWDOJODXFRPD
ಡଙ7KH'LIIHUHQW9LHZVIRU*ODXFRPD0DQDJHPHQW
घৈפֳણ൝ઘઅௗݑ
ࠕ०ඟ ʡᦩŝᄲᬱ
www.koreanglaucoma.org
11
9ROXPH_1XPEHU
ചടد
EORFNHUݴघৈਁࣳষڹؘऀઌਁࣳࡂد३ඛ़ܾ
ઌഡ ഥ࠾ਁ فഡ અѿ ੍ً ചടد घৈਁࣳ05
WLPROROઽ࣏ੋയڹ३હઌേણৢߜ٩ѿ
३હઌ WKHUDSHXWLF OHYHO ർূ Ҳ ٽ ़ѿ ઔৰࣳ ३ࣥ
ৈਁࣳ025WLPROROടݗڂࠤઽയڹ&KH\QH
6WRNHVEUHDWKLQJӘ30ਁઊݱؘߗඛࠋઙઍ੶دؘ
ࡂӋ٩ઔӋ२Ӌઔؘ18ґਖ਼घৈѿWLPROROઽ
࣏ੋടӋ२ઊ൛ٻӋEUDG\FDUGLDਭઅ२घ५ܾ
നৡ യدؘ ࡂӋ٩ ઔد3 گ܅ࣳ FDUGLDF DUUK\WKPLD֢
EURQFKRVSDVPઊઔؘ൝ৈਁؘ࣏ࣳੋനؘࣳٻӋીࣛહ ઌৈઊਁࣳ٩ѿ؟ഡ01֢025અ֯٩અઽ
࣏ੋടؘҫઊ੶DSQHDઅѿ؟ऀڹߚਁ३ࣥৈਁؘࣳ
Ԕඥ७ടਉ࣏ੋനৡഡد
&DUERQLFDQK\GUDVHLQKLELWRUઌGRU]RODPLGHਭEULQ]RODPLGH
ૻ घৈਁؘࣳ GRU]RODPLGHѿ ઘԔࣛઊ ِടਉ ࣷټ د घৈਁࣳ DFHWD]RODPLGHઅ ԃણੋܞ ӄസહઌ ҫ੶
ܾ540PJNJGD\࣏ઊਁࣳد৩ടҲ࣏ੋټدFDUERQLF
DQK\GUDVH LQKLERWRUઅ ԙԞؘ K\SRNDOHPLD K\SRQDWUHPLD
K\SHUFKORUHPLFDFLGRVLVVXOIRQDPLGHK\SHUVHQVLWLYLW\ڢ੶ܾ
ಡඥӄӴৢ࣏ੋഢڹઅѿًചടد३Ԟ؟ણ֢
७ഡҁԞ؟ણѿઔؘӄੌؘഗടؘҫઊӋӋੋܞৈ
फ़ഗݾ࣏ੋടӋઔؘ൝ઘਁؘࣳҎઊঌӄੌDQRUH[LD
WDFK\SQHDFRPDԪࡂӋټࠅѿઔ੶ܾ߳ޓੌઅݴഡ د3३ࣥৈਁࣳWRSLFDOGRU]RODPLGHݴশҫކ੶ܾPHWDEROLF
DFLGRVLVѿࠋࣥټҫઊࡂӋټࠅઔ੶ܾ߳३ࣥৈਁࣳઊ
ৢষڹؘৈԞѿઝޢӋ߄ߗҲѿઝѿടӋઔؘ
અԩҲࣔೞৡടӋઅ७ٽڹؘPHWDEROLFDFLGRVLVઅࣛઍ
़ઔ੶ܾ߳ଋ१ৢ֑Ӌചഡҩ࣏ݴ१രനৡഡد1
%ULPRQLGLQHUHODWLYH2VSHFLILFDJRQLVWܾԞ؟ઊ֢७ ࠆ़ ҆घݴ ܑടؘ ৌؘد घৈਁࣳઅ ടҋ൭Ә
ؘٻৼ੶֢੭ऀઊޓੌҋടਉ३ࣥৈਭਕৈઅ߸
ऀऽഡEORRGEUDLQEDUULHUݴॕҲ౿ӘടӋײਁ٩
ܾથടؘ2UHFHSWRUݴ౿ടਉૻஷ३ӄӆ٪ऀ֢ౌ
़ֶઔدਕৈਁࣳEUDG\FDUGLDK\SRWHQVLRQK\SRWKHUPLD
K\SRWRQLDѿ ࡂӋټ ࠅ ઔӋ घৈਁࣳ EULPRQLGLQHৢ
࣏ੋടӋ3060ֳ࡚ਁVRPQROHQFHUHVSLUDWRU\GHSUHVVLRQ
DSQHD७ৰFRPDԪࡂӋټࠅѿઔৰࣳৢ֑Ӌ൲੭
৺ઊ൦ࡃٻԞؘടਔކ22ं߸ކघৈਁ࣏ࣳੋടؘ
ҫԃણٻৌؘد1७ഡހെࣛઊ֢ߗԞܲҎૻ
ஷ३ӄӆӚܳࡘઙੋஔૻઊѿ࠻ң֢<20NJ֢ઊѿৰ
ݾघৈ<6ंਁࣳއઊࠋࣥടਔدؘӴѿઔد4
3URVWDJODQGLQDQDORJૻਁؘࣳODWDQRSURVW0005ѿघৈਁ
࣏ੋٻӋઔدघৈਁࣳઅऀӘ൭ӘؘࡂӋټҫઊއ
ৌٙڛӄੌਁ൭ӘѿઔؘৌӋ੭અഡട ҋ൭Әѿઔؘӄੌؘ֢ઊѿއӄലઊӋMXYHQLOHRSHQ
DQJOHJODXFRPD6WXUJH:HEHUV\QGURPHӘӚټפֳણಡ ඥ֢ઊѿއӄੌDSKDNLFJODXFRPDڢ੶ܾࡂӋٻৼد
घৈਁࣳODWDQRSURVWઅࡘઙੋࡂӋؘڙߜدҿޅாേҩ ਐഗࡘ࠹ࣞঋઊڂՂӋԢৰؘҫڙߜҲ़ણ
ࠋഡඛӍ܇Ә२൛ѿࡂӋٻৼ੶֢ൠࠉࡘઅ
ࡂӋؘ৺د1
3. 소아녹내장의 시력예후
ৰ֢ؖઊਁ֢ࣳפֳણ५ਁઊݴ़ઔؘ࠾ઊކ
घৈਁؘࣳࠋشૻઌ१Ҁӆਁفഡछࣛ੶ܾऀઌࡂ دً֢ࣃҿӘݴܑടҲټدघৈפֳણ൝ઘਁࣳਕӴ હઌ१ܲघ५અѿણඕഡઌૻടؘ֢ৢ१ઊפֳણ
੶ܾઌഡ१३ӄछࣛҀޅ࠾࠹७ഡӸઊ࣏ࣛ१ਁًട ਉؘۙઊୱહ੶ܾࠋࣥഢ़ઔدઊټҫઊௗݑ અ֙ઊৈإ܅હԔહઌৢ१ௗݑѿചടӋࣥஷહӚ
୵ઊചടدࣷפֳણ੶ܾઌഡEXSKWKDOPLFH\Hؘѿ࠷
਼ࣛਁ٩ৢടਉ़ࣳીஔӴֳേӴಶޏ ޅࠆݼѿઍৰ़֧ઔӋৰؖ१ઽਁ֢ࣳਁߚૂ
ѿࣥԢ़ઔ੶ऀӖહઌ़ी൲़ךઊ֥൲ਁ٩ഥ
࠾ઊࣥԢ़ઔد5
घৈפֳણ൝ઘઅ ம१ܲ ӠҀߗਁࣳ10Ԫد৩ട Ҳ֢ౌ़֧ઔކࠉહ੶ܾघৈפֳણ൝ৈઅ१ܲਙ
൲ؘ߆ടਉࣳ615ઊࣛઅ१ܲࡂઊؘӄੌѿ40
50612ઊࣛઅ१ܲࡂઊؘӄੌؘ2040ી٩ܾࡂӋ ٻӋઔدघৈઅીࣛઊৰݳࡂد֯੶ܾ߳19PP+J
ઊടܾടؘҫܾ16ंઊਁפֳણ
ଔزࠊ126ԑ116ךஷહӚ୵ഡӴਁࣳ٩66
612અ१ܲ29ਁࣳކѿ؟ടਔӋ१ܲش
ऀഡࡻੰSULPDU\LQIDQWLOHJODXFRPDѿ46ܾѿણӋ
VHFRQGDU\ JODXFRPD 40V\QGURPHDVVRFLDWHGJODXFRPD
22DSKDNLFJODXFRPD10અाઊৼد6घৈઅפֳણ
$[HQIHOG5LHJHUV\QGURPH3HWHUV’DQRPDO\DQLULGLD6WXUJH
:HEHUV\QGURPHSHUVLVWHQWSULPDU\K\SHUSODVWLFYLWUHRXV߸
ऽৈޏޅ࠾ڢدݳઊࣛઊઔؘਁࣳࠋࣥടؘӄੌѿ
އ੶ܾ߳פֳણਁઅഡ१३ӄछ਼ࣛਁ٩دݳٳࠉټઊ
Journal of The Korean Glaucoma Society
JOURNAL OF THE KOREAN GLAUCOMA SOCIETY 12
ࣛ੶ܾઌഡ१ܲ҆घѿઔ़ઔدפֳણઊઝٻӋ
دݳٳࠉټઅઊࣛઊ१ܲਁ߸ௗؘਕലઊહ़ܿৢ
१ਁઅഡ१ܲ҆घݴ੭અനৡഡد
4. 맺는 말
घৈઅӘଖ൝فടؘӘઅؘ࣏ऀઌӘشݼࠋشૻ
ઌघৈ१Ҁӆઅಡ़ऀ҆ടਉৢ१અਙࠒӘৢ१અௗ
ݑݴധࣛਐڂਁڂৰৡކഡدघৈઅפֳણ१३ӄઊ
֢ҀޅڢઅӴહ࠹൛਼ਁԕ१֢֥१ڢӸઊࣛ
ܑടؘӄੌѿއӋઊܟഡӄੌӸࡘڢڢӸઊࣛਁઅ ഡԞ؟હઌৢ१ѿࠋࣥഢ़ઔدৢ१ؘௗݑѿѿ؟ഡଖ
൝੶ܾפֳણ੶ܾઌഡӴ࠹൛ѿઔৰ٩Ԟ؟હৢ१ѿ
અ७ٻؘӄੌӸઊࣛઅӯીӘѿހௗݑ܅ؘઍࠉહઌৢ
१ௗݑѿ12ૻ10ਁࣳऀӖહઊৼدؘࡂӋ٩ઔد7घ
ৈפֳણ൝ৈਁࣳીԞહ੶ܾ൜ઌࢻৈإ܅Ӹҩ࣏
ਭ१ܲѿݴ१രടਉԞ؟હઌৢ१ݴԞࠋҽടӋહԔ હ੶ܾௗݑݴ१രടؘҫઊ൝ৈઅ१ܲਙ൲ݴ१ౄؘ
ٙԞਉഢ़ઔҫઊد
참고문헌
1. Coppens G, Stalmans I, Zeyen T, Casteels I. The safety and efficacy of glaucoma medication in the pedi- atric population. J Pediatr Ophthalmol Strabismus 2009;46:12-8.
2. Levy Y, Zadok D. Systemic side effects of ophthalmic drops. Clin Pediatr (Phila) 2004;43:99-101.
3. Wallace DK, Steinkuller PG. Ocular medications in chil- dren. Clin pediatr 1998;37:645-52.
4. Al-Shahwan S, Al-Torbak AA, Turkmani S, et al. Side- effect profile of brimonidine tartrate in children. Oph- thalmology 2005;112:2143.
5. Papadopoulos M, Khaw PT. Childhood glaucoma. In: Taylor D, Hoyt CS, eds. Pediatric Ophthalmology and Strabismus.
3rd ed. Edinburgh: Elsevier Ltd; 2005:458-71.
6. Kargi SH, Koc F, Biglan AW, Davis JS. Visual acuity in chil- dren with glaucoma. Ophthalmology 2006;113:229-38.
7. Kushner BJ. Successful treatment of functional amblyo- pia associated with juvenile glaucoma. Graefes Arch Clin Exp Ophthalmol 1988;226:150-3.